Changing the Public Perception: Why Clinical Trial Participation is Needed

Clinical study participant Nina Martinez and AbbVie researcher Maurizio Facheris encourage people to help advance science by participating in clinical trials.

Eyeforpharma Awards AbbVie with 2017 “Most Valuable Patient Initiative" and “Most Valuable Pharma Collaboration”

Led by AbbVie Israel, more than 300 health care stakeholders across the country collaborated to build the awarded project, YouTube’s “Doctor’s Channel.”

Could Ireland Hold the Genetic Codes to Crack Serious Diseases?

Genomic information from thousands of people in Ireland may unearth new clues in the hunt for markers of disease and new medicines to treat them.

For Children Without Books, A New Chapter Begins

For the man behind Bernie’s Book Bank, putting books into kids' hands isn't just a battle to increase literacy in underserved communities. It's a personal quest.

What’s Not Normal About That Time of the Month

Unearthing what is and isn’t normal about that time of the month may be the key to empowering women to discuss endometriosis.

Growing a Passion for Science

The first step to encouraging students to pursue STEM careers is helping them see the work – and themselves – in a new light.  

Five Breast Cancer Facts You Should Know

The San Antonio Breast Cancer Symposium, December 6 - 10, brings together academic researchers and health care professionals to share the latest research and advancements in the treatment/understanding of breast cancer.

New Ways to Treat Cancer: Combinations Could Change the Game

Oncology researcher Dr. Gary Gordon feels optimistic about the future of cancer treatment. Here’s why.

Our Commitment to the Most Common Adult Leukemia

Learn more about the symptoms and treatment of chronic lymphocytic leukemia (CLL).

Breaking the Chain of “Trading One Disease for Another”: Understanding Graft-Versus-Host with Lori Styles

Graft-Versus-Host Disease literally adds insult to injury. Preventing it will ensure transplant patients can finally move on with their lives.